25812-30-0

Gemfibrozil (CI-719) 是一种PPAR-α激活剂，可作为降脂药。它也是P450非选择性抑制剂，对 CYP2C9、2C19、2C8 和 1A2 的Ki 值分别为 5.8、24、69 和 82 μM。

Gemfibrozil (Standard) 是 Gemfibrozil 的标准品，适用于定量分析、质量控制及生化实验等相关研究。Gemfibrozil (CI-719) 是一种PPAR-α激活剂，可作为降脂药。它也是P450非选择性抑制剂，对 CYP2C9、2C19、2C8 和 1A2 的Ki 值分别为 5.8、24、69 和 82 μM。

Gemfibrozil-D6 is intended for use as an internal standard for the quantification of gemfibrozil by GC- or LC-MS. Gemfibrozil (T1415) is a peroxisome proliferator-activated reporter α and PPARγ agonist. In vivo,gemfibrozil reduces serum total cholesterol,triglyceride,and LDL levels in a rat model of high-cholesterol diet-induced hyperlipidemia. Gemfibrozil (T1415)reduces atherosclerotic plaque area,superoxide production,and expression of the genes encoding the NF-κB subunit p65 and chemokine (C-C)motif ligand 2 (CCL2)in ApoE-/- mice. Formulations containing gemfibrozil have been used in the treatment of high cholesterol.